113 related articles for article (PubMed ID: 2419740)
41. Modulation of the blood-aqueous barrier by gram positive and gram negative bacterial cell wall components in the rat and rabbit.
Kufoy EA; Fox K; Fox A; Parks C; Pakalnis VA
Exp Eye Res; 1990 Feb; 50(2):189-95. PubMed ID: 2311681
[TBL] [Abstract][Full Text] [Related]
42. Induction of tumoricidal macrophages and production of cytokines by synthetic muramyl dipeptide analogues.
Saiki I; Saito S; Fujita C; Ishida H; Iida J; Murata J; Hasegawa A; Azuma I
Vaccine; 1988 Jun; 6(3):238-44. PubMed ID: 2844032
[TBL] [Abstract][Full Text] [Related]
43. [Muramyl dipeptide and its synthetic analog as possible inducers of interleukin-2 production].
Malaĭtsev VV; Bogdanov IM; Sukhikh GT; Andronova TM
Biull Eksp Biol Med; 1985 Aug; 100(8):221-3. PubMed ID: 3875372
[TBL] [Abstract][Full Text] [Related]
44. The adjuvant activity of synthetic N-acetylmuramyl-dipeptide: evidence of initial target cells for the adjuvant activity.
Sugimura K; Uemiya M; Saiki I; Azuma I; Yamamura Y
Cell Immunol; 1979 Mar; 43(1):137-49. PubMed ID: 313841
[No Abstract] [Full Text] [Related]
45. In vitro and in vivo effects of MDP-Lys(L18) on mouse megakaryocyte progenitor cells (CFU-Meg).
Komiya I; Kuriya S; Akahane K; Nomura T
Exp Hematol; 1992 May; 20(4):517-22. PubMed ID: 1568468
[TBL] [Abstract][Full Text] [Related]
46. Demonstration of muramyl dipeptide (MDP)-induced T suppressor cells responsible for MDP immunosuppressive activity.
Leclerc C; Bourgeois E; Chedid L
Eur J Immunol; 1982 Mar; 12(3):249-52. PubMed ID: 6980118
[TBL] [Abstract][Full Text] [Related]
47. [The immunomodulating activity of new muramyl dipeptide derivatives in vitro].
Medvedev AE; Fuks BB; Bovin NV; Zemliakov AE
Biull Eksp Biol Med; 1992 Dec; 114(12):626-8. PubMed ID: 1292694
[TBL] [Abstract][Full Text] [Related]
48. Opposite effects of the synthetic adjuvant N-acetyl-muramyl-L-alanyl-D-isoglutamine on the immune response in mice depending on experimental conditions.
Souvannavong V; Adam A
Eur J Immunol; 1980 Aug; 10(8):654-6. PubMed ID: 6995138
[TBL] [Abstract][Full Text] [Related]
49. N-[trans-2-[[2'-(acetylamino)cyclohexyl]oxy]acetyl]-L-alanyl-D-glutamic acid: a novel immunologically active carbocyclic muramyl dipeptide analogue.
Kikelj D; Pecar S; Kotnik V; Stalc A; Wraber-Herzog B; Simcic S; Ihan A; Klamfer L; Povsic L; Grahek R; Suhadolc E; Hocevar M; Hönig H; Rogi-Kohlenprath R
J Med Chem; 1998 Feb; 41(4):530-9. PubMed ID: 9484503
[TBL] [Abstract][Full Text] [Related]
50. Dextran sulfate-mediated enhancement of mitogen-induced B-cell proliferation.
Bouwer HG; Hinrichs DJ
Cell Immunol; 1986 Feb; 97(2):316-24. PubMed ID: 2427219
[TBL] [Abstract][Full Text] [Related]
51. Modulation of the immunosuppressive activity of CKS-17, a synthetic retroviral envelope peptide, by muramyl dipeptide.
Gauduin MC; Vogel FR; Simon JP; Audibert FA; Chedid LA
Viral Immunol; 1993; 6(3):175-83. PubMed ID: 8292225
[TBL] [Abstract][Full Text] [Related]
52. Opposite effects of lipopolysaccharide and dextran sulfate on membrane phospholipid metabolism of murine B lymphocytes.
Morelec MJ; Ensergueix D; Pedron T; Girard R; Chaby R
Eur J Immunol; 1988 Feb; 18(2):301-7. PubMed ID: 2450758
[TBL] [Abstract][Full Text] [Related]
53. Stimulatory effect of N-acetyl Muramyl dipeptide in vivo: proliferation of bone marrow progenitor cells in mice.
Wuest B; Wachsmuth ED
Infect Immun; 1982 Aug; 37(2):452-62. PubMed ID: 7118246
[TBL] [Abstract][Full Text] [Related]
54. Functional bioassays for B cell growth factors using polyclonally activated murine spleen B cells.
Ruuth E; Couillin I; Herbelin A; Praz F
Lymphokine Res; 1989; 8(2):147-58. PubMed ID: 2471901
[TBL] [Abstract][Full Text] [Related]
55. Priming effect of muramyl peptides for induction by lipopolysaccharide of tumor necrosis factor production in mice.
Parant M; Parant F; Vinit MA; Jupin C; Noso Y; Chedid L
J Leukoc Biol; 1990 Feb; 47(2):164-9. PubMed ID: 2303750
[TBL] [Abstract][Full Text] [Related]
56. The effect of lipopolysaccharide from bacteroides gingivalis and muramyl dipeptide on osteoblast collagenase release.
Sismey-Durrant HJ; Atkinson SJ; Hopps RM; Heath JK
Calcif Tissue Int; 1989 May; 44(5):361-3. PubMed ID: 2540890
[TBL] [Abstract][Full Text] [Related]
57. Bacterial lipopolysaccharide, phorbol myristate acetate, and muramyl dipeptide stimulate the expression of a human monocyte surface antigen, Mo3e.
Todd RF; Alvarez PA; Brott DA; Liu DY
J Immunol; 1985 Dec; 135(6):3869-77. PubMed ID: 3934269
[TBL] [Abstract][Full Text] [Related]
58. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
[TBL] [Abstract][Full Text] [Related]
59. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
[TBL] [Abstract][Full Text] [Related]
60. Regulation by muramyl dipeptide (MDP) of the lymphoproliferative responses and polyclonal activation of human peripheral blood mononuclear cells.
Bahr GM; Modabber FZ; Morin A; Terrier M; Eyquem A; Chedid L
Clin Exp Immunol; 1984 Jul; 57(1):178-86. PubMed ID: 6744667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]